CPUH · Compute Health Acquisition Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - |
| SG&A | $10.0K | - | $965.3K | $616.7K | $533.4K | - | $419.8K | $663.8K | $343.7K |
| Total Operating Expenses | - | - | - | - | $372.4K | - | - | - | $392.0K |
| D&A | - | - | - | - | - | - | - | - | - |
| Operating Income | ($3.56M) | - | ($1.02M) | ($666.7K) | ($583.4K) | - | ($469.6K) | ($713.1K) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - |
| Income Tax | $202.1K | - | $808.5K | $219.4K | - | - | - | - | - |
| Net Income | ($13.30M) | - | $8.46M | $9.75M | $12.78M | - | $19.18M | ($10.69M) | ($5.18M) |
| EPS - Basic | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $281.0K | $765.8K | $1.01M | $66.8K | $272.5K | $836.9K | $958.7K | $1.07M | $47.1K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $42.4K | $4.2K | $22.4K | $10.9K | $24.4K | $8.0K | $267.8K | $147.7K | $117.9K |
| Current Assets | $421.0K | $1.01M | $1.28M | $537.4K | $942.8K | $1.61M | $1.91M | $2.20M | $47.1K |
| Total Assets | $96.96M | $95.34M | $868.36M | $864.38M | $863.56M | $864.16M | $864.44M | $864.72M | $863.89M |
| Current Liabilities | $3.23M | $1.38M | $1.65M | $252.3K | $78.4K | $371.0K | $968.1K | $791.4K | $310.1K |
| Long-term Debt | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $24.13M | $9.21M | $36.38M | $40.87M | $49.80M | $63.18M | $65.90M | $85.37M | $73.86M |
| Stockholders' Equity | ($23.53M) | ($8.27M) | ($34.29M) | ($39.71M) | ($48.74M) | ($61.52M) | ($63.96M) | $5.00M | $5.00M |
| Retained Earnings | ($23.53M) | ($8.27M) | ($34.29M) | ($39.71M) | ($48.74M) | ($61.52M) | ($63.97M) | ($15.87M) | ($5.2K) |
Cash Flow
| Line item | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($484.8K) | - | - | - | ($564.4K) | - | - | - | ($1.60M) |
| Investing Cash Flow | ($1.20M) | - | - | - | - | - | - | - | ($862.50M) |
| Financing Cash Flow | $1.20M | - | - | - | - | - | - | - | $864.12M |
| CapEx | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross margin | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | 8.7% | 2.2% | - | - | - | - | - |
| Return on assets | -13.7% | - | 1.0% | 1.1% | 1.5% | - | 2.2% | -1.2% | -0.6% |
| Return on equity | 56.5% | - | -24.7% | -24.6% | -26.2% | - | -30.0% | -213.7% | -103.7% |
| Return on invested capital | - | - | - | - | - | - | - | - | - |
| Liquidity | |||||||||
| Current ratio | 0.13 | 0.74 | 0.78 | 2.13 | 12.02 | 4.34 | 1.97 | 2.78 | 0.15 |
| Quick ratio | 0.13 | 0.74 | 0.78 | 2.13 | 12.02 | 4.34 | 1.97 | 2.78 | 0.15 |
| Cash ratio | 0.09 | 0.56 | 0.61 | 0.26 | 3.47 | 2.26 | 0.99 | 1.36 | 0.15 |
| Leverage | |||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - |
| Equity multiplier | -4.12 | -11.53 | -25.32 | -21.77 | -17.72 | -14.05 | -13.51 | 172.94 | 172.78 |
| Liabilities / Assets | 0.25 | 0.10 | 0.04 | 0.05 | 0.06 | 0.07 | 0.08 | 0.10 | 0.09 |
| Efficiency | |||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - |
| Valuation | |||||||||
| P / E | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - |
| Growth | |||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -510.5% | - | -116.2% | 6.5% | - | - | - | - | - |
| Net income growth (YoY) | - | - | -55.9% | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 51.7% | 86.6% | 46.4% | - | - | - | - | - | - |
Peer comparison
Same SIC group: Blank Checks
Comparing Compute Health Acquisition Corp. against the 5 most active filers in the same SIC group.